PRESS RELEASE published on 06/18/2024 at 10:00, 1 year 9 months ago Advancing Kidney Care With Solidified Evidence – SphingoTec Presents PenKid at AKI & CRRT Course in Vicenza SphingoTec introduces kidney function biomarker PenKid at AKI & CRRT Course. PenKid addresses AKI diagnostic gaps with real-time assessment and risk prediction capabilities SphingoTec PenKid Kidney Function Biomarker AKI & CRRT Course Biomarker Integration
BRIEF published on 03/26/2024 at 13:05, 2 years ago SphingoTec annonce des changements majeurs dans sa direction Biomarqueurs Innovations Diagnostiques Changements De Gestion SphingoTec Soin Critique
BRIEF published on 03/26/2024 at 13:05, 2 years ago SphingoTec Announces Major Management Changes Biomarkers Management Changes Diagnostic Innovations SphingoTec Critical Care
PRESS RELEASE published on 03/26/2024 at 13:00, 2 years ago SphingoTec Announces Management Changes SphingoTec announces changes in management team with new appointments. Deborah Bergmann appointed as CEO. Dr. Florian Uhle as CMO and Nicole Witzmann as CFO. Company aims to enhance critical care diagnostics Management Team Biomarkers SphingoTec Deborah Bergmann Critical Care Diagnostics
PRESS RELEASE published on 10/05/2023 at 10:00, 2 years 5 months ago New Formula Leverages Proenkephalin A 119-159 (penKid) for Improved GFR Estimation in Steady-State and Critically Ill Patients
PRESS RELEASE published on 09/06/2023 at 10:00, 2 years 6 months ago International Experts Highlight Demand for Diagnostic Innovations as PenKid's Research and Real-World Data Fuels Quest for Improved RRT Liberation Tools
PRESS RELEASE published on 08/31/2023 at 12:30, 2 years 6 months ago Boditech Med and SphingoTec close Market Development Agreement to Boost Commercialization of Kidney Function Biomarker PenKid
PRESS RELEASE published on 05/09/2023 at 10:00, 2 years 10 months ago SphingoTec's Innovative IVD Product sphingotest® penKid® Receives First IVDR Certificate
PRESS RELEASE published on 04/04/2023 at 10:00, 2 years 11 months ago ADQI Group Recognizes PenKid as Relevant Functional Biomarker for Sepsis-Associated Acute Kidney Injury
PRESS RELEASE published on 02/23/2023 at 10:00, 3 years 1 month ago SphingoTec Appoints Dr. Florian Uhle as Medical Director
Published on 03/26/2026 at 16:20, 1 hour 2 minutes ago ACCESS Newswire Upgrades the ACCESS Platform to Include Social Monitoring to Track Brand Conversations Across Major Social Platforms
Published on 03/26/2026 at 13:00, 4 hours 22 minutes ago Prospect Ridge Strengthens Technical Team with Appointment of Phil Smerchanski as Senior Technical Advisor
Published on 03/26/2026 at 13:00, 4 hours 22 minutes ago GameSquare's Stream Hatchet Launches Creator Communities to Manage the Full Creator Marketing Lifecycle
Published on 03/26/2026 at 12:59, 4 hours 23 minutes ago Adcore Concludes Fiscal Year 2025 With Strong Q4 Performance
Published on 03/26/2026 at 17:03, 18 minutes ago RM plc: 2025 Annual Report and Financial Statements and 2026 Annual General Meeting
Published on 03/26/2026 at 16:20, 1 hour 1 minute ago Sartorius AG Supervisory Board extends appointment of board member René Fáber
Published on 03/26/2026 at 15:25, 1 hour 56 minutes ago Duck Creek Loss Control Named 2026 Insurance Luminary Finalist by PropertyCasualty360
Published on 03/26/2026 at 15:23, 1 hour 58 minutes ago Sartorius AG - Resolutions of the Annual General Meeting
Published on 03/26/2026 at 07:30, 9 hours 52 minutes ago BIOPHYTIS-LYNXKITE ALLIANCE INVITED TO NVIDIA CONFERENCE: UNLEASHING AI TO REVOLUTIONIZE LONGEVITY
Published on 03/26/2026 at 07:30, 9 hours 52 minutes ago BIOPHYTIS ET LYNXKITE INVITÉS À LA CONFÉRENCE NVIDIA : L’IA AU SERVICE DE LA LONGÉVITÉ
Published on 03/25/2026 at 18:53, 22 hours 28 minutes ago CIS - Transfert Contrat de Liquidité Portzamparc - 25.03.2026
